Download the Precision Launch Perspectives Inspiration Pack
Win the moments that matter most
Because no two launches win in the same way, Prescient’s Precision Launch approach focuses on identifying the specific moments, decisions and strategic levers that will shape each launch’s trajectory. Our new Inspiration Pack, Precision Launch Perspectives, brings this approach to life through five articles from our Precision Launch experts, exploring how teams can define their Must-Win Moments, keep strategy aligned as evidence and competition evolve, and direct their effort toward the areas most likely to influence the outcome.
What’s inside
The pack opens with Maxine Smith’s One-Size-Fits-All Pharma Launches Are Over, which makes the case for shaping launch effort around the archetype and concentrating readiness on the few Must-Win Moments that determine a launch’s trajectory. Melissa Dagless builds on this in The New Drivers of Pharma Launch Uptake, drawing on research across hundreds of launches to show that archetype and therapy area together explain over 40% of the difference in uptake, with cost and promotion accounting for barely 1%.
In The Living Launch Plan, Ryan Caradonna and Sukanya Saha look at how teams can keep their strategy connected to the market by making critical assumptions visible, linking competitive intelligence to launch readiness and adapting as new evidence emerges.
The final two articles explore how Must-Win Moments play out in specific therapy areas. Sanam Sikander-Rehman and Sarah Appelbaum examine what it takes to succeed in immunology, and Pippa Macnair’s The Precision Paradox considers how biomarker-led oncology launches depend on testing, trial design and access decisions made from Phase II onward.
Explore the articles
- Launching in Immunology | Sanam Sikander-Rehman and Sarah Appelbaum
Key takeaways from PHLEX 2026
At the Pharma Launch Excellence Conference in Boston, we presented our Precision Launch approach to launch leaders from Marketing, Insights, Access and Medical. The pack shares five themes from those discussions, covering the growing need for insight from abundant data, the challenge of achieving differentiation, and the importance of evidence planning that keeps pace with the market.
Built on the Precision Launch approach
Each launch has its own critical moments, whether that means building the system that finds patients in rare disease or making sure biomarker testing happens early enough to influence treatment in oncology. Our Precision Launch approach combines launch archetyping, therapy-area expertise, proprietary benchmarking and experience from more than 250 launches to identify what matters most in each scenario.
250+ launches | 42+ countries | 4 specialist practices
Explore our Precision Launch approach
Benchmark your launch capabilities
The pack also introduces LExLevel Pulse, an assessment across seven core launch excellence levers that provides a personalized benchmark report showing how your capabilities compare with industry standards. The Launch Excellence Report 2026 adds further context by showing where launch teams across global, regional and country roles currently stand.
Take the assessment | Download the report
